Mutated peptide of p53 to reduce TNF-alpha and LITAF production

The Portal is a joint project of MATTO and the MTTC. The development and implementation of the portal has been paid for by the MTTC, Beth Israel Deaconess Medical Center, Boston Biomedical Research Institute, Boston University, Brandeis University, Caritas St. Elizabeth's Medical Center, Boston Children's Hospital, Dana Farber Cancer Institute, Harvard University, Joslin Diabetes Center, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, McLean Hospital, Northeastern University, The Schepens Eye Research Institute, and Tufts University.

Intellectual Property

ID:		06-37
IP Type:		Licensable Technology
Title:		Mutated peptide of p53 to reduce TNF-alpha and LITAF production
Inventor:		Amar, Salomon
Summary:		This invention is a 7 amino acid stretch of p53 (pep 12) that substantially modulates inflammatory cytokines and reduces their activity. Reduction of inflammatory cytokines is important in numerous clinical applications including CrohnÕs Disease, RA, diabetes, etc.
Tech Type:		Therapeutics - Drugs
URL:		http://ctf-fmfe.bu.edu/BU0637.pdf
Contact:		Ashley J. Stevens, cives@bu.edu, 617 358 4550
Organization:		Boston University

Display all intellectual properties for Amar, Salomon
Display all intellectual properties for Boston University